The National Cancer Institute and the Avon Foundation recently granted awards to six applicants as part of the "Avon-NCI Progress For Patients" awards program for breast cancer research. The six awards, totaling 2.5 million dollars, will help fund innovative research in areas such as prevention and therapy. These are the first recipients from the program, which was launched a year ago. Dr. Jorge Gomez is from the NCI and is involved in the project.
"The objective of this particular program is to support early phase clinical interventions in areas of diagnosis, prevention, treatment, prognosis and early detection. Basically I'm talking about phase one and phase two of clinical trials. We're also focusing on medically underserved (patients) and on training, if possible, of new investigator's."
More than 200-thousand people, mostly women, have been diagnosed with invasive breast cancer since 1998 in the U.S. Of that number, approximately 50-thousand will die. This is Kelly Persinger, the National Institutes of Health, Bethesda, Maryland.